Jove
Visualize
联系我们
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策

相关概念视频

Blood Studies for Cardiovascular System I: Cardiac Biomarkers01:20

Blood Studies for Cardiovascular System I: Cardiac Biomarkers

1.2K
Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
1.2K
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers01:19

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers

765
Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
765
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

790
Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
790

您也可能阅读

相关文章

通过共同作者、期刊和引用图与本文相关的文章。

排序
Same author

Phase II trial of enfortumab vedotin in patients with previously treated gastric and esophageal cancers.

ESMO open·2025
Same author

Climate-related challenges to brain health: A European perspective review.

Revue neurologique·2025
Same author

Clinical significance of activin A and myostatin in patients with pancreatic adenocarcinoma and progressive weight loss.

Journal of physiology and pharmacology : an official journal of the Polish Physiological Society·2020
Same author

The wine polyphenol resveratrol modulates autophagy and induces apoptosis in MOLT-4 and HL-60 human leukemia cells.

Journal of physiology and pharmacology : an official journal of the Polish Physiological Society·2020
Same author

Mesenchymal Stem Cells as a Salvage Treatment for Severe Refractory Graft-vs-Host Disease in Children After Bone Marrow Transplantation.

Transplantation proceedings·2019
Same author

Rejuvenation of allogenic red cells: benefits and risks.

Vox sanguinis·2018

相关实验视频

Updated: May 1, 2026

Postconditioning with Lactate-enriched Blood for Cardioprotection in ST-segment Elevation Myocardial Infarction
05:26

Postconditioning with Lactate-enriched Blood for Cardioprotection in ST-segment Elevation Myocardial Infarction

Published on: May 28, 2019

11.1K

矩阵金属蛋白酶-2有助于心脏中的缺血-再输液损伤.

P Y Cheung1, G Sawicki, M Wozniak

  • 1Departments of Pediatrics, University of Alberta, Edmonton, Alberta, Canada.

Circulation
|April 19, 2000
PubMed
概括

在再输液期间急性释放的矩阵金属蛋白酶 (MMP) 在缺血后恶化心脏功能. 抑制MMP可以治疗缺血-再输血损伤.

科学领域:

  • 心血管研究研究心血管研究
  • 生物化学 生物化学
  • 药理学 药理学是指药理学的学科.

背景情况:

  • 矩阵金属蛋白酶 (MMPs) 涉及到心肌梗塞后的细胞外矩阵重塑.
  • MMPs在缺血-再输血诱导的心肌功能障碍中的直接作用尚不清楚.

研究的目的:

  • 为了研究MMPs在隔离大鼠心中的缺血-再输液期间的释放和功能影响.
  • 评估MMP抑制作为潜在的治疗策略,用于缺血-再输血损伤.

主要方法:

  • 隔离, perfused 鼠心受到全球无流动性缺血症,然后再输血.
  • 在冠状动脉废水中测量MMPs (pro-MMP-2,MMP-2,75-kDa凝酶).
  • 评估心脏机械功能的恢复.
  • 使用MMP-2抗体,多西环素和o-phenanthroline的药理干预.

主要成果:

  • 在再注射过程中,PromMP-2的释放到冠状动脉废水中显著增加,在第一分钟内达到峰值.
  • 增加的亲MMP-2释放与机械功能恢复有负相关性.
  • 抑制MMP (多西环素,o-phenanthroline) 和MMP-2抗体改善了功能恢复,而MMP-2则使其恶化.

更多相关视频

Blood Circuit Reconstruction in an Abdominal Mouse Heart Transplantation Model
08:37

Blood Circuit Reconstruction in an Abdominal Mouse Heart Transplantation Model

Published on: June 3, 2021

4.4K
Improved Rodent Model of Myocardial Ischemia and Reperfusion Injury
07:23

Improved Rodent Model of Myocardial Ischemia and Reperfusion Injury

Published on: March 7, 2022

8.8K

相关实验视频

Last Updated: May 1, 2026

Postconditioning with Lactate-enriched Blood for Cardioprotection in ST-segment Elevation Myocardial Infarction
05:26

Postconditioning with Lactate-enriched Blood for Cardioprotection in ST-segment Elevation Myocardial Infarction

Published on: May 28, 2019

11.1K
Blood Circuit Reconstruction in an Abdominal Mouse Heart Transplantation Model
08:37

Blood Circuit Reconstruction in an Abdominal Mouse Heart Transplantation Model

Published on: June 3, 2021

4.4K
Improved Rodent Model of Myocardial Ischemia and Reperfusion Injury
07:23

Improved Rodent Model of Myocardial Ischemia and Reperfusion Injury

Published on: March 7, 2022

8.8K

结论:

  • 在再注射过程中,MMP-2的急性释放会导致心脏机械功能障碍.
  • 抑制MMP是一种潜在的新型治疗方法,用于缺血-再输液损伤.